Critical issues in the use of vasoactive substances to assess lund microvascular injury.
D000809:Angiotensins / Q000378:metabolism; D000818:Animals; D002415:Cats; D004285:Dogs; D000860:Hypoxia / Q000378:metabolism; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008833:Microcirculation / Q000378:metabolism; D008954:Models, Biological; D009929:Organ Size; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D011652:Pulmonary Circulation / Q000187:drug effects; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism
D000809:Angiotensins; D011453:Prostaglandins; D012701:Serotonin; D007703:Peptidyl-Dipeptidase A